학술논문
Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas.
Document Type
Article
Author
Source
Subject
*RITUXIMAB
*LYMPHOMAS
*T-cell lymphoma
*T cells
*
*
*
Language
ISSN
2075-4426
Abstract
Peripheral T-cell lymphomas (PTCLs) are a group of heterogeneous lymphomas with poor overall prognosis, particularly in the setting of relapsed/refractory PTCL. Given the limited efficacy of current therapies, several different novel therapies encompassing multiple different mechanisms of action have been evaluated for relapsed and refractory PTCLs. In this review, we explore the current standard of care for relapsed/refractory PTCL, and evaluate in depth novel and emerging therapies, their scientific basis, and current trials for relapsed/refractory PTCL. [ABSTRACT FROM AUTHOR]